Average Co-Inventor Count = 2.44
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merrell Dow Pharmaceuticals (17 from 455 patents)
2. Merrell Pharmaceuticals, Inc. (4 from 194 patents)
3. Other (1 from 832,680 patents)
4. Hoechst Marion Roussel (1 from 236 patents)
5. Aventis Pharmaceuticals Inc. (1 from 207 patents)
6. Aventis Pharma Limited (39 patents)
7. Marion Merrell Dow Canada Inc. (0 patent)
8. Gestion De La Sante Marion Merrell Dow Canada Inc.-marion Merrell Dow Canada Health Management Inc. (0 patent)
9. Boyd L. Harrison (0 patent)
10. Bruce M. Baron (0 patent)
24 patents:
1. 7777042 - N-sulfonylpipecolic acid derivative FKBP binding composition and pharmaceutical use thereof
2. 5922752 - NMDA (n-methyl-d-aspartate) antagonists
3. 5703107 - 3-aminoindolyl derivatives
4. 5675018 - 3-amidoindolyl derivatives
5. 5606063 - NMDA antagonists
6. 5519048 - 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical
7. 5500419 - NMDA antagonists
8. 5491153 - 3-amidoindolyl derivative
9. 5489579 - Potentation of NMDA antagonists
10. 5470870 - NMDA antagonists
11. 5441963 - Potentiation of NMDA antagonists
12. 5407954 - Arylalkoxyphenoxy-imidazoline compounds
13. 5360814 - NMDA antagonists
14. 5326756 - R-4-oxo-5 phosphononorvaline used as NMDA antagonists
15. 5318985 - Potentiation of NMDA antagonists